NIMHD DSS: Dr. O. Kenrik Duru

Presentation Objectives

• Guidelines recommend primary diabetes screening but also secondary screening for diabetes-related complications, and disparities vary by phase of screening
• There are arguments both for and against race-based primary diabetes screening
• Black/African American, Latino/Hispanic, and Native American/Alaska Native patients are less likely than White patients to successfully achieve primary and secondary diabetes prevention, due to social and environmental pressures

O. Kenrik Duru , M.D., M.S., Professor of Medicine at the David Geffen School of Medicine, received a Doctorate of Medicine from the University of California San Francisco and a Master of Science in Health Services from the UCLA Fielding School of Public Health.

Dr. Duru's research interests include enhancing physical activity among older adults from racial and ethnic minority groups and designing interventions to reduce disparities in medication adherence and clinical outcomes among patients with diabetes. He also has a strong career/research focus on diabetes care and prevention and working with populations experiencing health disparities.

He has experience leading research on health and health care disparities for both racial and ethnic minority populations and populations with lower socioeconomic status, as well as in studying barriers and facilitators of adherence to medications for chronic conditions, including diabetes and hypertension. Dr. Duru has a strong interest in mentoring current and future scientists who are underrepresented in medicine. Go to Dr. Duru’s full bio.

Seminar Logistics

• The seminar will be videocast and available on this page and in the NIH Video archives after the presentation.
• Sign language interpreters will be provided upon request.

• Individuals who need reasonable accommodation to participate should contact Edgar Dews (phone: 301-402-1366) at least five business days before the event.